Ann: Quarterly Activities Report and Appendix 4C, page-33

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 33 Last

Share
Profile

Follow
fattchoi

6,768 Posts.

4475

27/07/22

10:30

Post #: 62748640
Share

Originally posted by gedck ↑

To be honest - I was expecting even more of Pfizer's money to have been spent than this. Of course there has been no real growth in the actual core business - our board have been too busy trying to convince everyone to give the business and their investments away...

Seriously - anybody in their actual right and logical mind can see the enormous potential of this technology and business.

If only we had competent and professional leaders, with experience in global health-tech commercialisation, who are genuinely dedicated to pro-actively advancing and commercialising the company, and acting not only in the best interests of shareholders, but also passionate about the implementation of what clearly is, and should be, such critically important and useful contemporary technology for today's world.

A large-scale global partner would of course be helpful too.

Where things have ended up for this company is so frustrating and disappointing. And, in my opinion, the burden of that responsibility lies completely in the failure of management - at so many critical junctures in the journey of this company.

How unsurprising that our conference call is postponed. Such a disappointment.

Expand

I totally agree with your sentiment. I have said this years ago and I will say it again. This management team is cRAP!!! One could even give them a Rolls Royce and they will sell it for the price of a e-scooter! And even that it would be an achievement in itself.

RAP Price at posting: 12.0¢ Sentiment: None Disclosure: Not Held
6 Upvote

0 Great analysis

Reply

Top Stories

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

What's causing the cost-of-living crisis, and how to navigate it

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon